Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2004-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-004-0507-yPMID 15127235PMCID PMC11032847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ULBP4 is a novel ligand for human NKG2D.

  2003cited by this paper
• Roles of the NKG2D immunoreceptor and its ligands

  2003cited by this paper
• IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells.

  2003cited by this paper
• Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events

  2003cited by this paper
• The Contribution of NKT Cells, NK Cells, and Other γ-Chain-Dependent Non-T Non-B Cells to IL-12-Mediated Rejection of Tumors 1

  2003cited by this paper
• Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

  2003cited by this paper
• Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

  2003cited by this paper
• Preferential Survival of CD8 T and NK Cells Expressing High Levels of CD94 1

  2003influential reference
• Deciphering the relationship between central and effector memory CD8+ T cells.

  2003cited by this paper
• Natural killer cells and cancer.

  2003cited by this paper
• The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct.

  2003cited by this paper
• Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.

  2003cited by this paper
• Tumors as elusive targets of T-cell-based active immunotherapy.

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• Differentiation of CD8+ T Cells from Tumor-Invaded and Tumor-Free Lymph Nodes of Melanoma Patients: Role of Common γ-Chain Cytokines1

  2003cited by this paper
• Modulation of costimulation to enhance tumor immunity

  2003cited by this paper
• The NK cell receptor repertoire: formation, adaptation and exploitation.

  2003cited by this paper
• Immune functions encoded by the natural killer gene complex

  2003cited by this paper
• Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity

  2003cited by this paper
• Analysis of HLA-E expression in human tumors

  2003cited by this paper
• On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases

  2003cited by this paper
• Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells

  2003cited by this paper
• HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

  2003cited by this paper
• Selective Activation of the c-Jun NH2-terminal Protein Kinase Signaling Pathway by Stimulatory KIR in the Absence of KARAP/DAP12 in CD4+ T Cells

  2003cited by this paper
• The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

  2002cited by this paper
• Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• CD28 downregulation and expression of NK-associated receptors on T cells in aging and situations of chronic activation of the immune system

  2002cited by this paper
• Cutting Edge: Analysis of Human Vα24+CD8+ NK T Cells Activated by α-Galactosylceramide-Pulsed Monocyte-Derived Dendritic Cells

  2002cited by this paper
• Valpha24+ NKT cells are decreased in elderly humans.

  2002cited by this paper
• Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

  2002cited by this paper
• Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.

  2002cited by this paper
• Variable receptors controlling activation and inhibition of NK cells.

  2002cited by this paper
• Peptide‐specific CD8+ T‐cell evolution in vivo: Response to peptide vaccination with Melan‐A/MART‐1

  2002cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002cited by this paper
• Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

  2002cited by this paper
• NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56

  2002cited by this paper
• Activation and inhibition of lymphocytes by costimulation.

  2002cited by this paper
• The use of HLA class I tetramers to design a vaccination strategy for melanoma patients

  2002cited by this paper
• Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.

  2002cited by this paper
• Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants

  2002cited by this paper
• UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells

  2002cited by this paper
• Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.

  2002cited by this paper
• The B7–CD28 superfamily

  2002cited by this paper
• Selective Depletion of CD56dim NK Cell Subsets and Maintenance of CD56bright NK Cells in Treatment-Naive HIV-1-Seropositive Individuals

  2002cited by this paper
• Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation

  2002cited by this paper
• Vα24+ NKT cells are decreased in elderly humans

  2002cited by this paper
• Inhibition of CD28-mediated natural cytotoxicity by KIR2DL2 does not require p56(lck) in the NK cell line YT-Indy.

  2002cited by this paper
• Expression of stress-induced MHC class I related chain molecules on human melanoma.

  2002cited by this paper
• MICA triggering signal for NK cell tumor lysis is counteracted by HLA‐G1‐mediated inhibitory signal

  2002cited by this paper
• Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1

  2002cited by this paper
• Immunity against cancer: lessons learned from melanoma.

  2001cited by this paper
• Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells

  2001cited by this paper
• ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

  2001cited by this paper
• The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.

  2001influential reference
• Human CD8+ T cells expressing HLA‐DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells

  2001cited by this paper
• Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment

  2001cited by this paper
• Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions1

  2001cited by this paper
• CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

  2001cited by this paper
• The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector αβ T Cells1

  2001cited by this paper
• B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8+ T Lymphocytes In Vivo

  2001cited by this paper
• The self peptide annexin II (208–223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells

  2001cited by this paper
• Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.

  2001cited by this paper
• Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1

  2001cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

  2001cited by this paper
• Impaired Perforin-Dependent NK Cell Cytotoxicity and Proliferative Activity of Peripheral Blood T Cells is Associated with Metastatic Melanoma

  2001cited by this paper
• Expression of CD94 and NKG2 molecules on human CD4+ T cells in response to CD3‐mediated stimulation

  2001cited by this paper
• Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

  2001cited by this paper
• Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation1

  2001cited by this paper
• Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice1

  2001cited by this paper
• In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma

  2001cited by this paper
• Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells.

  2001cited by this paper
• Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells

  2001cited by this paper
• Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

  2001cited by this paper
• Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function.

  2000cited by this paper
• CD56 DIRECTLY INTERACTS IN THE PROCESS OF NCAM‐POSITIVE TARGET CELL‐KILLING BY NK CELLS

  2000cited by this paper
• Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

  2000cited by this paper
• How much longer will tumour cells fool the immune system?

  2000cited by this paper
• Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression

  2000cited by this paper
• A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1

  2000cited by this paper
• Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1

  2000cited by this paper
• Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

  2000cited by this paper
• Restoration of Alloreactivity of Melanoma by Transduction With B7.1

  2000cited by this paper
• Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.

  2000cited by this paper
• Analysis of Human Vα24+ CD4+ NKT Cells Activated by α-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells

  2000cited by this paper
• Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T‐cell‐depleted bone marrow transplant recipients

  2000cited by this paper
• HLA-class I-specific inhibitory receptors in HIV-1 infection.

  2000cited by this paper
• Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244)1

  2000cited by this paper
• Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.

  2000cited by this paper
• Regulation of IFN-gamma production following 2B4 activation in human NK cells.

  2000cited by this paper
• Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice

  2000cited by this paper
• 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness

  2000cited by this paper
• A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance

  2000cited by this paper
• Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression1

  2000cited by this paper
• NKT cells: facts, functions and fallacies.

  2000cited by this paper
• Transforming growth factor‐β‐induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes

  1999cited by this paper
• Molecular cloning and biological characterization of NK cell activation‐inducing ligand, a counterstructure for CD48

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper

• Current progress in NK cell biology and NK cell-based cancer immunotherapy

  2020cites this paper
• HLA y expresión de receptores NK en pacientes con melanoma

  2016cites this paper
• Revisiting the paradigm on the putative need for antigen-specific responses in cancer

  2015cites this paper
• CHARACTERIZATION OF DIFFERENTIATION AND PROGNOSTIC BIOMARKERS ON CD8+ TUMOR-INFILTRATING LYMPHOCYTES IN METASTATIC MELANOMA

  2013cites this paper
• The Tumor Microenvironment: A Pitch for Multiple Players

  2013cites this paper
• NK Cells in Healthy Aging and Age-Associated Diseases

  2012cites this paper
• Human Adipose-Derived Stem Cells Impair Natural Killer Cell Function and Exhibit Low Susceptibility to Natural Killer-Mediated Lysis

  2012cites this paper
• Revisiting the paradigm on the putative need for antigen-specific responses in cancer

  2011cites this paper
• CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease

  2011cites this paper
• Age-Dependent Association between Low Frequency of CD27/CD28 Expression on pp65 CD8 (cid:1) T Cells and Cytomegalovirus Replication after Transplantation (cid:1)

  2009cites this paper
• Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

  2009cites this paper
• Age-Dependent Association between Low Frequency of CD27/CD28 Expression on pp65 CD8+ T Cells and Cytomegalovirus Replication after Transplantation

  2009cites this paper
• NK Cells in Human Ageing

  2009cites this paper
• Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells.

  2009cites this paper
• Positive psychosocial factors and NKT cells in ovarian cancer patients.

  2008cites this paper
• Functional Implications of HNK-1 Expression on Invasive Behaviour of Melanoma Cells

  2008cites this paper
• Remodelling of the CD8 T-Cell Compartment in the Elderly: Expression of NK Associated Receptors on T-Cells Is Associated with the Expansion of the Effector Memory Subset

  2007cites this paper
• Distribution of natural killer cells and T-lymphocyte subsets in peripheral blood, gallbladder cancer and surrounding tissue.

  2007cites this paper
• Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.

  2007cites this paper
• Activation of Cytotoxic T Lymphocyte Responses and Attenuation of Tumor Growth in vivo by Andrographis paniculata Extract and Andrographolide

  2007cites this paper
• Natural Killer Receptors on CD8 T Cells and Natural Killer Cells from Different HLA-C Phenotypes in Melanoma Patients

  2006cites this paper
• Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

  2006cites this paper
• Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

  2006cites this paper
• CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype

  2005cites this paper
• Human natural killer cells: a comprehensive review.

  2005cites this paper
• Human immunosenescence: is it infectious?

  2005cites this paper